Claims
- 1. A compound of the formula 1 ##STR24## wherein: X is an oxygen atom or nothing;
- R.sup.1 is hydrogen, alkyl of 1 to 4 carbon atoms, fluoroalkyl of 1 to 4 carbon atoms and 1 to 3 fluorine atoms, cycloalkyl of 3 to 6 carbon atoms, alkylthio of 1 to 2 carbon atoms, alkyloxy of 1 to 2 carbon atoms, oxetanyl, thietanyl, tetrahydrofuranyl, tetrahydrothienyl, tetrahydropyranyl, tetrahydrothiopyranyl, alkenylmethyl or alkynylmethyl of 3 to 4 carbon atoms, alkyloxyalkyl or alkylthioalkyl of 2 to 3 carbon atoms, alkanoyl or alkyl(thiocarbonyl) of 2 to 5 carbon atoms, or cyanoalkyl of 2 to 3 carbon atoms;
- R.sup.2 is hydrogen, methyl or ethyl;
- R.sup.3 is a hydrogen atom, alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, alkenyl or alkynyl of 2 to 6 carbon atoms, trihalomethyl, hydroxyalkyl of 1 to 6 carbon atoms, alkyloxy or alkylthio of 2 to 6 carbon atoms, alkyloxyalkyl or alkylthioalkyl of 2 to 6 carbon atoms, pyrrolidinyl, pyrrolinyl, piperidinyl, mono-or di-alkylamino wherein each alkyl moiety contains 1 to 3 carbon atoms, halogen, cyano, nitro, or carboxyl, aryl (wherein aryl is phenyl, pyridinyl, thienyl, furanyl, pyrrolyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl or isothiazolyl) which is either unsubstituted or substituted by hydroxyl, amino, halogen, alkyl or alkyloxy of 1 to 3 carbon atoms.
- 2. A compound of formula 1, as set forth in claim 1,
- wherein:
- X is nothing;
- R.sup.1 is hydrogen, alkyl of 1 to 3 carbon atoms, cycloalkyl of 3 to 4 carbon atoms, alkylthio of 1 to 2 carbon atoms;
- R.sup.2 is hydrogen, methyl or ethyl;
- R.sup.3 is a hydrogen atom, methyl, trihalomethyl, alkyloxy or alkylthio of 1 to 2 carbon atoms, pyrrolidinyl, pyrrolinyl, piperidinyl, di-alkylamino wherein each alkyl moiety contains 1 to 2 carbon atoms, halogen, cyano, aryl (wherein aryl is phenyl, pyridinyl, thienyl, furanyl, pyrrolyl, imidazolyl, pyrazolyl, oxazoly), isoxazolyl, thiazolyl or isothiazolyl) which is either unsubstituted or substituted by hydroxyl, amino, halogen, alkyl or alkyloxy of 1 to 3 carbon atoms.
- 3. 5,11 dihydro-11-ethyl-2-methoxy5-methyl-dipyrido�3,2-b:2',3'-e!azepine-6-one;
- 5,11-dihydro-11-ethyl-2-(4-pyrazolyl)-5-methyl-dipyrido�3,2-b:2',3'-e!azepine-6-one,
- and the pharmaceutically acceptable salts thereof.
- 4. A method for inhibiting HIV-1 replication in a human host infected by HIV-1, which comprises administering to such host an amount of a compound of formula 1, as set forth in claims 1, 2, or 3, or a pharmaceutically acceptable salt thereof, which is sufficient to inhibit HIV-1 replication.
- 5. A method for treating HIV-1 infection which comprises administering, to a human being exposed to or infected by HIV-1, a therapeutically effective amount of a compound of formula 1, as set forth in claims 1, 2, or 3, or a pharmaceutically acceptable salt thereof.
- 6. A pharmaceutical composition suitable for treating HIV-1 infection which comprises a therapeutically effective amount of a compound of formula 1, as set forth in claims 1, 2, or 3, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.
CROSS-REFERENCE TO RELATED APPLICATIONS
The benefit of prior provisional application Ser. No. 60/055,189, filed on Aug. 11, 1997, is hereby claimed.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
5366972 |
Hargrave et al. |
Nov 1994 |
|
Non-Patent Literature Citations (3)
Entry |
Kelly et al. (J. Med. Chem. (1995), 38(24), 4839-470). |
Hargrave et al. (J. Med. Chem. (1991), 34, 2231-2241). |
Dalpiaz et al. (J. Med. Chem. (1995), 38, 4730-4738). |